Skip to Main Content

Paper Details

Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.
Nephrol Dial Transplant
42
2017
ADPKD, PKD, Patients, autosomal dominant polycystic kidney disease, participants, patients
Author NameAffiliation
Alan S L YuKansas University Medical Center
Michael F FlessnerNational Institutes of Health
Michael F FlessnerNational Institutes of Health
  • 1 - 3

Datasets

Release 1.2